Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
Key takeaway
Medicare coverage of GLP-1 drugs has added 700,000 new senior patients, with Eli Lilly capturing 70% of this growth.
- Step 1 · The triggerMedicare coverage of GLP-1 drugs removes the affordability barrier for seniors, adding 700,000 new patients to the treated population.
- Step 2 · Knock-onEli Lilly captures 70% of the incremental Medicare demand, expanding its GLP-1 prescription volumes and revenue base.
- Step 3 · Knock-onNovo Nordisk, as the other main GLP-1 supplier, benefits from overall category growth, though with a smaller share.
- Step 4 · Reaches youUS healthcare SMEs supplying GLP-1 providers experience higher order volumes and steadier cash flow as Medicare-backed demand expands.
The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.
Source: CNBC
See what today’s news does to your business. Atri by Branch² — Early-warning intelligence for your businessThis is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.